Tevogen Inc. Increase (Decrease) in Other Operating Assets
Tevogen Inc. (TVGN) reported Increase (Decrease) in Other Operating Assets of $3 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-14
- Tevogen Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $3.00.
- Tevogen Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $500.00K, a 12.98% increase year-over-year.
- Tevogen Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- Tevogen Inc. increase (decrease) in other operating assets for the quarter ending 2024-12-31 was $442.56K.
- Tevogen Inc. increase (decrease) in other operating assets for fiscal 2025 was $490.04K, a 4.10% decline from fiscal 2024.
- Tevogen Inc. increase (decrease) in other operating assets for fiscal 2024 was $511.01K.
- Tevogen Inc. increase (decrease) in other operating assets for fiscal 2023 was -$323.74K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-03-31 | $3.00 10-Q · filed 2026-05-15 | $500.00K derived: sum of 2 quarters · filed 2026-05-15 | $500.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $500.00K derived: sum of 2 quarters · filed 2026-03-31 | $490.04K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$9.96K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | -$9.96K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $442.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $442.56K derived: sum of 2 quarters · filed 2026-03-31 | $442.56K derived: sum of 3 quarters · filed 2026-03-31 | $511.01K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $68.45K 10-Q · filed 2025-11-14 | -$233.95K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $68.45K 10-Q · filed 2025-08-14 | -$233.95K derived: sum of 3 quarters · filed 2025-08-14 | -$233.95K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $68.45K 10-Q · filed 2025-05-14 | -$233.95K derived: sum of 2 quarters · filed 2025-05-14 | -$233.95K derived: sum of 3 quarters · filed 2025-05-14 | -$233.95K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$302.40K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | -$302.40K derived: sum of 2 quarters · filed 2025-04-02 | -$302.40K derived: sum of 3 quarters · filed 2025-04-02 | -$323.74K 10-K · filed 2025-04-02 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $1.00 derived: sum of 2 quarters · filed 2024-11-19 | -$21.34K 10-Q · filed 2024-11-19 | |
| 2023-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$21.34K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$21.34K 10-Q · filed 2024-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |